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n this report, we show that zinc is required for endoplasmic
reticulum function in 
 
Saccharomyces cerevisiae
 
. Zinc
deﬁciency in this yeast induces the unfolded protein re-
sponse (UPR), a system normally activated by unfolded ER
proteins. Msc2, a member of the cation diffusion facilitator
(CDF) family of metal ion transporters, was previously im-
plicated in zinc homeostasis. Our results indicate that
Msc2 is one route of zinc entry into the ER. Msc2 localizes
to the ER when expressed at normal levels. UPR induction
I
 
in low zinc is exacerbated in an 
 
msc2
 
 mutant. Genetic and
biochemical evidence indicates that this UPR induction is
due to genuine ER dysfunction. Notably, we found that
ER-associated protein degradation is defective in zinc-limited
 
msc2
 
 mutants. We also show that the vacuolar CDF proteins
Zrc1 and Cot1 are other pathways of ER zinc acquisition.
Finally, zinc deﬁciency up-regulates the mammalian ER
stress response indicating a conserved requirement for zinc
in ER function among eukaryotes.
 
Introduction
 
Zinc is an important cofactor for many proteins that reside
in or pass through organelles of the secretory system. For exam-
ple, packaging of insulin in secretory granules of pancreatic
 
 
 
-cells is dependent on Zn
 
2
 
 
 
 (Huang and Arvan, 1995;
Dodson and Steiner, 1998). Matrix metalloproteases are
Zn
 
2
 
 
 
-requiring enzymes that are secreted by cells to modify
the ECM during development and tumor cell metastasis
(Chang and Werb, 2001). These proteins acquire zinc at
an early point in the secretory pathway (Pei and Weiss,
1995; Kang et al., 2002). Addition of phosphoethanolamine
groups to glycosylphosphatidylinositol (GPI) anchors re-
quires Zn
 
2
 
 
 
-dependent enzymes in the ER (Galperin and
Jedrzejas, 2001; Mann and Sevlever, 2001; Sevlever et al.,
2001). As a last example, some protein chaperones homolo-
gous to 
 
Escherichia coli
 
 DnaJ, like the ER-localized Scj1 of
 
Saccharomyces cerevisiae
 
, likely require Zn
 
2
 
 
 
 to function in
protein folding and in the degradation of misfolded proteins
by quality control mechanisms (Silberstein et al., 1998;
Nishikawa et al., 2001; Tang and Wang, 2001; Linke et al.,
2003). These many requirements for Zn
 
2
 
 
 
 in the secretory
pathway highlight the need for zinc transporters to deliver
the metal to those organelles. Despite the importance of
these various zinc-dependent processes in normal cell func-
tion and disease states such as cancer, the transport proteins
responsible for zinc delivery have not yet been identified.
Members of the cation diffusion facilitator (CDF) family
of transport proteins are likely candidates to transport Zn
 
2
 
 
 
into the secretory pathway. CDF proteins play conserved
roles in transporting Zn
 
2
 
 
 
 from the cytosol into organelles
or out of the cell in many organisms (Nies and Silver, 1995;
Paulsen and Saier, 1997; Gaither and Eide, 2001; Palmiter
and Huang, 2004). In 
 
E. coli
 
, for example, the ZitB CDF
protein transports excess zinc from the cytosol to the extra-
cellular environment (Grass et al., 2001). In mammals,
ZnT-1 similarly transports excess cytosolic zinc, whereas
ZnT-2 may detoxify the metal by sequestering it in the late
endosome (Palmiter and Findley, 1995; Palmiter et al.,
1996; Kobayashi et al., 1999). Three mammalian CDF pro-
teins implicated in Zn
 
2
 
 
 
 transport into the secretory path-
way are ZnT-5, ZnT-6, and ZnT-7, each of which having
been localized to the Golgi apparatus (Huang et al., 2002;
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Kambe et al., 2002; Kirschke and Huang, 2003). The func-
tional roles of these proteins are not yet clear.
We have learned much about zinc homeostasis from stud-
ies of the yeast 
 
S. cerevisiae
 
. In this yeast, zinc uptake is me-
diated by the high affinity Zrt1 transporter and the lower af-
finity Zrt2 and Fet4 proteins (Zhao and Eide, 1996a,
1996b; Waters and Eide, 2002). The genes encoding these
transporters are controlled by the Zap1 transcriptional acti-
vator protein (Zhao and Eide, 1997). Zap1 is active in zinc-
limited cells and its activity is repressed in zinc-replete cells.
Zap1 binds to one or more zinc-responsive elements (ZREs)
in the promoters of its target genes (Zhao et al., 1998).
Zinc storage and detoxification in 
 
S. cerevisiae
 
 is mediated
by the vacuole. The Zrc1 and Cot1 proteins, both members
of the CDF family, are responsible for zinc transport into the
vacuole (Kamizono et al., 1989; MacDiarmid et al., 2000,
2002; Miyabe et al., 2001). Two other CDF proteins, Mmt1
and Mmt2, have been implicated in iron transport in the mi-
tochondria (Li and Kaplan, 1997). The fifth yeast CDF
member, and the subject of this report, is Msc2. Msc2 was
first identified in a screen for mutations with altered frequen-
cies of meiotic sister chromatid exchange (Thompson and
Stahl, 1999). However, the link between DNA recombina-
tion and the 
 
MSC2
 
 gene is unclear; the effects on recombina-
tion are allele specific and not observed in a full 
 
msc2
 
 deletion
mutant (Thompson and Stahl, 1999). A more recent study of
Msc2 suggested that it played some role in zinc metabolism
(Li and Kaplan, 2000). An 
 
msc2
 
 mutant grew poorly on re-
spired carbon sources at elevated temperatures and had an
abnormally large cell size. Both of these phenotypes were
suppressed by addition of excess zinc. In this report, we dem-
onstrate that Msc2 is an ER membrane protein whose role is
to maintain proper function of the ER. Our results indicate
that key processes in the ER require Zn
 
2
 
 
 
 and that Msc2 is
involved in supplying Zn
 
2
 
 
 
 to this compartment.
 
Results
 
Zinc deficiency induces the unfolded protein response 
(UPR)
 
Genome-wide cDNA microarray analysis of gene expression
in 
 
S. cerevisiae
 
 indicated that many genes (458) are induced
by zinc deficiency (Lyons et al., 2000). This included 46 di-
rect Zap1 targets and 412 genes up-regulated in a Zap1-
independent fashion. Induction of this latter group probably
reflects indirect effects of zinc deficiency on cell function.
Among the genes indirectly affected by zinc were several in-
volved in the UPR. The UPR is a response to the accumula-
tion of unfolded proteins in the ER (Patil and Walter,
2001). Fig. 1 A summarizes the microarray results for eight
genes of the UPR (Travers et al., 2000) that were up-regu-
lated by twofold or more in zinc-deficient wild-type cells.
The up-regulation of these genes is independent of Zap1;
each showed similar induction by zinc deficiency in a 
 
zap1
 
mutant. The UPR genes induced by zinc deficiency include
 
ERO1
 
, 
 
EUG1
 
, and 
 
PDI1
 
 (encoding proteins involved in
protein disulfide isomerization) and 
 
FKB2
 
 (encoding pepti-
dyl-prolyl cis-trans isomerase). In addition, 
 
JEM1
 
, 
 
KAR2
 
,
 
LHS1
 
, and 
 
SCJ1
 
 were also up-regulated. These genes encode
ER chaperones that facilitate the translocation of misfolded
ER proteins back to the cytosol for degradation in a process
known as ER-associated degradation (ERAD).
These data indicated that zinc deficiency up-regulates the
UPR. To confirm this hypothesis, we used a UPR-respon-
sive reporter gene to assess the effect of zinc deficiency on
UPR induction. UPR target genes contain UPRE sequences
in their promoters that confer this regulation. A UPRE-
 
lacZ
 
reporter was highly induced in wild-type cells grown in low
zinc (Fig. 1 B, LZM 
 
 
 
 0.3 
 
 
 
M Zn) relative to zinc-replete
cells (Fig. 1 B, LZM 
 
 
 
 1,000 
 
 
 
M Zn). These experiments
were performed using LZM medium which is zinc-limiting
due to addition of 1 mM EDTA. Adding as little as 10 
 
 
 
M
ZnCl
 
2
 
 to LZM was sufficient to repress UPRE-
 
lacZ
 
 expres-
sion. UPRE-
 
lacZ
 
 induction in low zinc was also observed in
 
zrt1
 
 mutants defective for zinc uptake. Because Zrt1 is the
major zinc uptake transporter in yeast, the 
 
zrt1
 
 mutant is
zinc deficient when grown in LZM supplemented with
 
 
 
300 
 
 
 
M ZnCl
 
2
 
 (Zhao and Eide, 1996a). The UPRE-
 
lacZ
 
reporter showed high levels of 
 
 
 
-galactosidase activity in the
 
zrt1
 
 mutant over a wide range of zinc concentrations and
Figure 1. Zinc deficiency induces the UPR. (A) Microarray analysis 
of UPR target genes showing greater than or equal to twofold induction 
in low zinc over high zinc in both wild-type and zap1 mutant cells. 
These data are from experiments described previously (Lyons et al., 
2000). (B) UPRE-lacZ activity in wild type (WT, DY1457) and the 
zrt1 mutant (ZHY1) over a range of zinc concentrations in LZM. 
LZM is zinc limiting because 1 mM EDTA is added to limit metal 
availability. Shown are representative data from two experiments. 
(C) HIS4-lacZ activity in DY1457 and ZHY1 in low (1  M) and high 
(1,000  M) zinc in LZM. Shown are representative data from two 
experiments. The error bars indicate   1 SD. 
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was suppressed only by adding 1,000 
 
 
 
M zinc to the media
(Fig. 1 B). A 
 
HIS4-lacZ
 
 control reporter, which is not re-
sponsive to either zinc or unfolded proteins, showed high ex-
pression in both the wild-type and the 
 
zrt1
 
 mutant strains at
all zinc concentrations (Fig. 1 C). Therefore, the effects seen
with the UPRE-
 
lacZ
 
 reporter are specific UPR effects and
not general effects on 
 
 
 
-galactosidase activity. The twofold
increase in UPRE-
 
lacZ
 
 expression observed between 30 and
100 
 
 
 
M zinc (Fig. 1 A) is similar to that seen with other
promoters (Fig. 1 C, 
 
HIS4-lacZ
 
) and probably reflects a gen-
eral decrease in expression in severely zinc-deficient cells.
 
Msc2 localizes to the ER
 
Induction of the UPR in low zinc suggested that zinc trans-
port into the lumen of the ER is required for ER function. A
transporter protein possibly involved in delivering zinc into
the ER is encoded by the 
 
MSC2
 
 gene. Previous studies sug-
gested that Msc2 was localized to the endoplasmic reticu-
lum. However, these experiments were done under condi-
tions where Msc2 was overexpressed. Because overexpression
can result in protein mislocalization, the true intracellular
location of Msc2 was unclear. Therefore, we determined the
localization of Msc2 when expressed from its own promoter
on a low copy plasmid. To aid detection of Msc2, we gener-
ated an 
 
MSC2
 
 allele with three HA tags fused to its COOH
terminus. Immunoblots detected only a single band near
the predicted molecular mass of Msc2 (unpublished data).
Moreover, the epitope-tagged protein complemented the
temperature-sensitive growth defect phenotype of an 
 
msc2
 
mutant strain indicating that it is functional.
Attempts to determine the subcellular localization of
Msc2 using immunofluorescence microscopy were inconclu-
sive because the level of expression was too low. Therefore,
we used sucrose gradient fractionation to assess the distribu-
tion of Msc2. Protein extracts of wild-type cells expressing
HA-tagged Msc2 were separated on sucrose gradients. After
centrifugation, fractions were collected and analyzed by im-
munoblotting. Previous reports have shown that the pres-
ence or absence of Mg
 
2
 
 
 
 greatly alters the position of ER
vesicles in the gradient (Roberg et al., 1997). Without added
Mg
 
2
 
 
 
, the ER colocalizes with the Golgi apparatus in the
middle fractions of the gradient. However, in the presence
of Mg
 
2
 
 
 
, the ER localizes to the heavier fractions of the gra-
dient, colocalizing with the plasma membrane. This shift to
heavier fractions is likely due to ribosomes remaining associ-
ated with the ER when Mg
 
2
 
 
 
 is present. If Msc2 localizes to
the ER, we predicted that the protein would show this
Mg
 
2
 
 
 
-dependent shift in these gradients.
Kex2 is a Golgi marker protein and its localization, peak-
ing around fraction 6 in the middle of the gradients (Fig. 2),
was unaffected by Mg
 
2
 
 
 
. A plasma membrane protein,
Pma1, also was largely unaffected by Mg
 
2
 
 
 
 levels with its
peak localization in the heaviest fractions of both gradients.
Dpm1 served as an ER marker. Both Msc2 and Dpm1
showed the diagnostic ER Mg
 
2
 
 
 
 shift being found in the
heavier fractions with Mg
 
2
 
 
 
 and localizing in the middle
fractions without Mg
 
2
 
 
 
. Because Msc2 colocalizes with an
ER marker protein and shows the characteristic ER Mg
 
2
 
 
 
shift, these studies strongly support the localization of Msc2
to that compartment. In the presence of Mg
 
2
 
 
 
, some Msc2
was also found in lighter fractions that may correspond to
the Golgi. Little Dpm1 was found in these lighter fractions.
 
Mutation of MSC2 alters zinc homeostasis
 
If Msc2 transports zinc into the ER lumen, we predicted that
mutation of the 
 
MSC2
 
 gene would alter homeostasis of cyto-
solic labile zinc. A useful bioassay of this labile zinc is the
Zap1 transcription factor, which binds to ZREs in it target
promoters. Zap1 is active in zinc-limited cells and repressed
by high zinc. The zinc response curve of a ZRE-
 
lacZ
 
 reporter
in wild-type cells is shown in Fig. 3 A. If Msc2 transported
zinc into the ER, we predicted that cytosolic zinc levels would
increase in an 
 
msc2
 
 mutant strain and repress Zap1 activity.
Consistent with this prediction, expression of the ZRE-
 
lacZ
 
reporter was suppressed in 
 
msc2
 
 cells grown in LZM 
 
 
 
 0.3–
10 
 
 
 
M ZnCl
 
2
 
 (Fig. 3 A). Mutation of 
 
MSC2
 
 did not decrease
expression of the 
 
HIS4-lacZ
 
 reporter indicating that the ef-
fects of the 
 
msc2
 
 mutation were specific to the ZRE-
 
lacZ
 
 re-
porter (Fig. 3 B). These results suggest that Msc2 transports
zinc from the cytosol into the ER lumen.
 
Effects of msc2 mutation on UPR induction
 
If Msc2 transports zinc into the ER, we predicted that an
 
msc2 mutant would increase induction of the UPR in low
Figure 2. Msc2 is localized to the endo-
plasmic reticulum. Lysates were prepared 
from wild-type (WT, DY150) cells express-
ing either pMSC2HA and pSN222 (Kex2-
HA) or pGEV-TRP and pRK315 (Pma1-
HA). Extracts were layered onto sucrose 
gradients for subcellular fractionation. Gra-
dient fractions were subjected to immuno-
blotting and probed with anti-HA or anti-
Dpm1 antibodies. Fractions are numbered 
from 1 (heaviest) to 11 (lightest). Shown 
are representative data from three experi-
ments. (A) Plot of immunoblot band inten-
sities from fractions prepared  Mg. (B) 
Plot of immunoblot band intensities from 
fractions processed  Mg. The lines la-
beled ER, PM, and Golgi denote fractions 
containing  50% of the peak values for 
the corresponding marker protein.328 The Journal of Cell Biology | Volume 166, Number 3, 2004
zinc relative to wild-type cells. This prediction was con-
firmed using the UPRE-lacZ reporter (Fig. 4 A). Although
the wild-type strain showed some induction of the UPR in
low zinc, this up-regulation was substantially increased in
the msc2 mutant strain. These data suggest that a strain lack-
ing MSC2 experiences greater ER stress when coupled with
zinc deficiency. To determine the metal specificity of this ef-
fect, we measured UPRE-lacZ expression in an msc2 mutant
under low zinc conditions when higher levels of zinc or
other metals were added. Although as little as 10  M zinc
suppressed the UPR up-regulation, neither 10 nor 100  M
of Fe
2 , Cu
2 , Cd
2 , Mn
2 , Ni
2 , or Co
2  greatly sup-
pressed this up-regulation (Fig. 4 B). Therefore, UPR induc-
tion in an msc2 mutant is a zinc-specific effect.
UPRE-lacZ induction by low zinc and msc2 mutation 
requires a functioning UPR signaling pathway
UPR induction is achieved through a two-protein signaling
pathway (for review see Patil and Walter, 2001). Ire1 is a
transmembrane endo-RNase protein that senses unfolded
proteins in the ER. Hac1 is the transcription factor that re-
sponds to that signal to increase expression of UPR target
genes. When Ire1 is activated by unfolded ER proteins, it
cleaves an intron out of the HAC1 mRNA. The spliced
HAC1 mRNA is translated into protein (Hac1
i), which then
up-regulates UPR target genes. To verify that the induction
of the UPR in an msc2 mutant is dependent on the Ire1–
Hac1 signaling pathway, we constructed msc2 ire1 and msc2
hac1 double mutants and analyzed their UPRE-lacZ activity.
DTT, a known inducer of the UPR because of its ability
to disrupt disulfide bonds in ER proteins, did not cause
UPRE-lacZ induction in ire1 and hac1 mutants in both the
wild-type and the msc2 mutant backgrounds (unpublished
data). These mutants were also impaired for induction of the
UPR in low zinc (Fig. 5 A). These strains had no such effect
on the control HIS4-lacZ reporter (not depicted). Therefore,
the induction of the UPR in low zinc in an msc2 mutant re-
quires the full UPR signaling pathway.
One can also envisage that an msc2 mutant may somehow
hyperactivate Hac1
i independently of Ire1. To test this hy-
pothesis, we introduced an intron-less form of the HAC1
gene on a low copy plasmid (pHac1
i) into both wild-type and
msc2 mutant strains. This plasmid-encoded Hac1
i does not
rely on Ire1 for its activation, and therefore causes constitu-
tive UPR induction. We predicted that if the msc2 mutation
made endogenous Hac1
i more active, it would have a similar
effect on plasmid-encoded Hac1
i. This was not the case. In-
troduction of pHAC1
i into wild-type cells actually caused
Figure 3. The msc2 mutation increases labile zinc levels. (A) ZRE-
lacZ activity in wild type (WT, DY150) and the msc2 mutant (DY150 
msc2) grown over a range of zinc concentrations in LZM. Shown are 
representative data from five experiments. (B) HIS4-lacZ activity in 
wild type (WT, DY150) and the msc2 mutant (DY150 msc2) in low 
(1  M) and high (1,000  M) zinc in LZM. Shown are representative 
data from five experiments. The error bars indicate   1 SD.
Figure 4. The msc2 mutant increases UPR induction in zinc 
deficiency. (A) UPRE-lacZ activity in wild-type (WT, DY150) and 
the msc2 mutant (DY150 msc2) over a range of zinc concentrations 
in LZM. Shown are representative data from three experiments. (B) 
UPRE-lacZ activity in the msc2 mutant in LZM   0.3  M Zn. The 
control condition, C, had no added metals. Shown are representative 
data from two experiments. The error bars indicate   1 SD.
Figure 5. The msc2 mutant requires Ire1 and Hac1 for UPR 
induction. (A) UPRE-lacZ activity in wild type (WT, DY150), msc2 
(DY150 msc2), ire1 (CEY3), hac1 (CEY4), msc2 ire1 (CEY5), and 
msc2 hac1 (CEY6) in low (1  M) and high (1,000  M) zinc in LZM. 
Shown are representative data from three experiments. (B) UPRE-
lacZ activity in wild type (WT, DY150) and the msc2 mutant 
(DY150 msc2) expressing vector (pRS315) or pHAC1
i in low (1  M) 
zinc in LZM. Shown are representative data from five experiments. 
The error bars indicate   1 SD.Zinc, Msc2, and ER function | Ellis et al. 329
higher levels of UPRE-lacZ activity than was observed in the
msc2 mutant (Fig. 5 B). Although the reason for the de-
creased expression in the mutant is not yet known, this result
clearly demonstrates that the msc2 mutation does not increase
Hac1
i activity independently of the UPR signaling pathway.
Genetic and biochemical evidence for ER dysfunction 
in msc2 mutants
The requirement for an intact Ire1–Hac1 signaling pathway
to induce the UPR in response to low zinc and loss of Msc2
function suggested that these factors perturbed ER function.
Further evidence supporting this conclusion came from the
observation that msc2 ire1 and msc2 hac1 mutants exhibit
a synthetic lethal growth phenotype. msc2 single mutants
grow poorly at 37 C on YP medium supplemented with
glycerol and ethanol, two nonfermentable carbon sources,
but show no such defect on media supplemented with glu-
cose (YPD), a fermentable carbon source (Fig. 6). Similarly,
neither ire1 nor hac1 mutants exhibit a growth defect on
YPD at either 30 or 37 C. Combining these mutations, i.e.,
msc2 ire1 and msc2 hac1, resulted in a strong growth defect
at 37 C. (The few colonies seen in the msc2 hac1 mutant at
37 C may be the result of spontaneously arising suppressor
mutations. More than 99% of the inoculated msc2 hac1 cells
failed to grow at the elevated temperature.) Introducing the
MSC2 or HAC1 genes on low copy plasmids (pMSC2,
pHAC1) back into the msc2 hac1 mutant restored growth at
37 C. Thus, an msc2 mutant requires both Ire1 and Hac1 to
survive at higher temperatures.
To further test the hypothesis that msc2 mutation and low
zinc causes ER dysfunction, we examined one aspect of
ER function, degradation of unfolded proteins through the
ERAD pathway. This particular aspect was addressed because
Scj1, an ER lumenal chaperone required for ERAD function,
has two predicted zinc binding sites and is likely to require
zinc for its activity. The homologous E. coli DnaJ protein was
shown to be zinc dependent (Tang and Wang, 2001; Linke
et al., 2003). A useful assay of the ERAD system is to moni-
tor the degradation of CPY*, a mutant carboxypeptidase Y
protein that fails to fold properly and is degraded by ERAD
(Finger et al., 1993). Wild-type and msc2 mutants were trans-
formed with a plasmid expressing CPY* bearing an HA
epitope tag (Ng et al., 2000). The cells were grown in high or
low zinc and then treated with cycloheximide to block fur-
ther protein synthesis. Aliquots were removed periodically
over 60 min for protein extraction and immunoblotting. No
difference was observed between wild-type and msc2 mutants
in either growth condition (unpublished data).
The UPR system induces expression of Scj1 and a second,
partially redundant chaperone called Jem1 (Fig. 1; Nishikawa
and Endo, 1997). Although Scj1 is probably zinc dependent,
Jem1 lacks the zinc-binding sites and is therefore likely to be
zinc independent. Therefore, increased expression of the Jem1
chaperone may compensate for the loss of zinc-dependent
Scj1 activity. To test this hypothesis, we examined CPY* deg-
radation in jem1 mutant cells lacking the zinc-independent
chaperone. CPY* turnover in a jem1 single mutant was rapid
in both zinc-limited and replete cells (Fig. 7). CPY* degrada-
tion in zinc-replete jem1 msc2 mutants was indistinguishable
from the jem1 single mutant. However, the jem1 msc2 mutant
showed a marked defect in CPY* degradation in low zinc.
Figure 6. The msc2 mutant is synthetically lethal with ire1 and 
hac1 at elevated temperatures. Yeast cells were grown in YPD or 
SD liquid medium overnight. Cultures were diluted in fresh media 
and 5  l vol (10
4 cells) were plated onto YPD plates, incubated at 
30 or 37 C, and photographed after 2 d. Wild type (WT, DY150), 
msc2 (DY150 msc2), ire1 (CEY3), hac1 (CEY4), msc2 ire1 (CEY5), 
and msc2 hac1 (CEY6) were grown and diluted in YPD before 
plating; msc2 hac1   pMSC2 and msc2 hac1   pHAC1 were 
grown and diluted in SD before plating.
Figure 7. The msc2 mutant has defects 
in ERAD in low zinc. LZM cultures of 
jem1 (CEY13), jem1 msc2 (CM164), and 
jem1 scj1 (CEY17) expressing the CPY*–
HA plasmid (pDN436U) were grown in 
the presence of cycloheximide for 0–60 
min before protein extraction. Extracts 
were analyzed by immunoblotting using 
mouse anti-HA or mouse anti-Pgk1 anti-
bodies. The intensities of the CPY*–HA 
bands were normalized to the Pgk1 bands. 
Each time point was then calculated as the 
percentage of the zero time point (To) for 
that strain. Shown are the averages of four 
experiments. (A) Plot of percent of To for 
cultures grown in low (1  M) zinc in LZM. 
(B) Plot of percent of To for cultures grown 
in high (1,000  M) zinc in LZM.330 The Journal of Cell Biology | Volume 166, Number 3, 2004
These studies indicate that zinc deficiency impairs function of
components, likely Scj1, of the ERAD system. Consistent
with this hypothesis, CPY* degradation was defective in a
jem1 scj1 double mutant at both zinc levels (Fig. 7).
Zrc1 and Cot1 also contribute to ER zinc
The ability of elevated zinc to suppress UPRE-lacZ induc-
tion in an msc2 mutant (Fig. 4 A) indicated that other trans-
porters in addition to Msc2 may also provide zinc to the ER.
Two possible candidates for this role are Zrc1 and Cot1,
members of the CDF protein family that transport zinc into
the vacuole. Although the steady-state location of these pro-
teins is the vacuole membrane, they must transit through the
ER en route to that compartment. Therefore, we tested
the contribution of Zrc1 and Cot1 to ER function using the
UPRE-lacZ reporter. Consistent with Zrc1 and/or Cot1 also
contributing to ER zinc, induction of the UPRE-lacZ re-
porter was greatly increased in a zinc-deficient msc2 zrc1 cot1
triple mutant relative to an msc2 mutant or wild-type cells
(Fig. 8 A). To determine if either or both Zrc1 and Cot1
were involved, we generated a series of single and double
mutants and assayed their effects on UPRE-lacZ induction
in low zinc and high zinc. In high zinc, all strains tested ex-
hibited no UPRE-lacZ induction (Fig. 8 B). Under zinc-
deficient conditions, zrc1, cot1, and zrc1 cot1 cells showed
UPR induction indistinguishable from wild-type cells. Zinc-
deficient msc2 mutant cells had increased UPRE-lacZ ex-
pression that was further increased in the msc2 zrc1 and msc2
cot1 mutants. Finally, UPRE-lacZ induction was highest in
the msc2 zrc1 cot1 mutant. These results suggested that all
three transporters contribute to ER function.
Zinc deficiency induces the UPR in mammalian cells
Finally, we addressed if the effects of zinc deficiency on the
UPR was evolutionarily conserved. In mammals, ATF6 is a
member of the basic-leucine zipper family of transcription
factors that acts analogously to yeast Hac1 to control the
UPR (for review see Harding et al., 2002). ATF6 contains a
transmembrane domain and is localized to the ER mem-
brane. Upon ER stress, ATF6 is proteolytically cleaved to re-
lease the NH2-terminal b-Zip–containing domain which
then translocates into the nucleus to activate UPR gene ex-
pression. To address if zinc deficiency activates the UPR
in mammalian cells, we examined the effects of zinc defi-
ciency on expression of an ATF6-responsive reporter plasmid
(p5xATF6GL3; Wang et al., 2000) transiently transfected
into HeLa cells. p5xATF6GL3 contains five copies of the
ATF6 binding site inserted upstream of the firefly luciferase
gene. These cells were cotransfected with a lacZ gene driven
by the SV40 promoter to normalize for differences in trans-
fection efficiency. As shown in Fig. 9 A, treating HeLa cells
bearing p5xATF6GL3 with tunicamycin, a glycosylation in-
hibitor and known inducer of ATF6 activity, resulted in a
marked induction of luciferase expression. To induce zinc
deficiency, cells were treated with 5  M of the zinc chela-
tor N,N,N ,N -tetrakis-(2-pyridyl-methyl)ethylenediamine
(TPEN). Cells were then harvested over a 12-h period and
assayed for luciferase expression. After 5 h of TPEN treat-
ment, a small increase in luciferase activity was observed
(Fig. 9 B). After 12 h, luciferase activity was induced ap-
proximately fourfold. No loss of cell viability was detected
over this 12-h period (unpublished data) indicating that the
induction was not due to necrosis or apoptosis. To deter-
mine the concentration of TPEN optimal to triggering UPR
induction, we assayed the effects of a range of TPEN con-
centrations after a 12-h treatment. TPEN concentrations
of   3  M had no effect on ATF6 activity whereas concen-
trations of 4 or 5  M induced expression above basal levels
(Fig. 9 C). Finally, we addressed if the effects of TPEN on
UPR induction were due to zinc deficiency or a pharmaco-
logical effect of TPEN. Consistent with zinc deficiency be-
ing the cause, simultaneous incubation of cells with 5  M
TPEN and 5  M ZnCl2 failed to induce ATF6 activity (Fig.
9 D). These results suggest that the requirement of the ER
for zinc is evolutionarily conserved and that zinc deficiency
induces the UPR in a wide range of organisms.
Discussion
In a previous report, Li and Kaplan (2000) proposed that
Msc2 transports zinc out of the nucleus into the cytosol.
This hypothesis was based on the tentative localization of
overexpressed Msc2 to the nuclear envelope (which is con-
tiguous with the ER membrane) and the observation that
the Zap1 transcription factor was completely repressed un-
der their zinc-deficient conditions in an msc2 mutant. We
questioned this hypothesis because the relatively large size of
Figure 8. Zrc1 and Cot1 may also transport zinc into the ER. (A) 
UPRE-lacZ activity in wild type (WT, CM100), msc2 (CEY7), and 
msc2 zrc1 cot1 (CEY8) over a range of zinc concentrations in LZM. 
Cells were grown in LZM   10  M Zn to deplete internal zinc stores 
before inoculation. Shown are representative data from three experi-
ments. (B) UPRE-lacZ activity in cells grown in low (1  M) and high 
(1,000  M) zinc in LZM: wild type (WT, CM100), zrc1 (CM102), 
cot1 (CM103), zrc1 cot1 (CM104), msc2 (CEY7), msc2 zrc1 (aver-
ages of CEY19-21), msc2 cot1 (averages of CEY22, 23), and msc2 
zrc1 cot1 (averages of CEY8, CEY27-29). Shown are data from one 
representative experiment done in triplicate. Letters refer to values 
that are significantly different from each other, as determined using 
the Scheffe’s test, with P   0.05. The error bars indicate   1 SD.Zinc, Msc2, and ER function | Ellis et al. 331
the nuclear pore is unlikely to limit diffusion of Zn
2  ions
between the cytosol and the nucleus (Shulga et al., 2000). In
this report, we propose the alternative model that zinc is re-
quired for ER function and Msc2 transports the metal into
the ER lumen.
Several lines of evidence support the hypothesis that Msc2
is involved in zinc metabolism. First, Msc2 is a member of
the CDF family of metal ion transporters. Studies of CDF
proteins in many organisms have established that these pro-
teins transport their metal ion substrate, usually Zn
2 , from
the cytosol to either outside of the cell or into organelles
(Nies and Silver, 1995; Paulsen and Saier, 1997; Gaither
and Eide, 2001; Palmiter and Huang, 2004). Thus, Msc2 is
likely to be a zinc transporter whose topology is consistent
with metal transport into the ER lumen. Second, mutations
in msc2 alter zinc homeostasis. Although it was shown previ-
ously that the Zap1 transcription factor was completely in-
active in a zinc-limited msc2 mutant (Li and Kaplan, 2000),
our experiments further clarified these earlier results by
showing that Zap1 can still respond to zinc deficiency in an
msc2 strain. Nonetheless, the suppression of ZRE-lacZ ex-
pression caused by the msc2 mutation that we observed (Fig.
3) is consistent with msc2 mutants having elevated pools of
labile cytosolic zinc. Third, mutations in MSC2 result in
several phenotypes that are zinc suppressible. Li and Kaplan
(2000) had shown that the growth defect of msc2 mutants
on respired carbon sources at elevated temperatures is sup-
pressed by zinc. Here, we document that zinc-deficient cells
up-regulate their UPR system and this induction is further
increased in an msc2 mutant. Like the temperature-sensitive
growth phenotype, induction of the UPR is zinc suppress-
ible. Finally, we present here genetic evidence that known
zinc transporters, Zrc1 and Cot1, play redundant roles with
Msc2. Their involvement in ER function indicates that
Msc2 is also a zinc transporter.
Our results indicate that Msc2 delivers zinc to the lumen
of the ER to maintain function of that compartment and,
perhaps, other organelles of the secretory pathway. Although
currently available methods do not allow us to assay lumenal
ER zinc directly, several observations indirectly support this
hypothesis. First, we found that Msc2 localizes to the ER
when expressed at physiological levels from its own pro-
moter. The presence of significant amounts of Msc2 protein
in vesicles of lighter density (Fig. 2 A,  Mg
2 ) suggests that
some protein may also be found in later compartments of
the secretory pathway, perhaps the Golgi. Second, mutation
of MSC2 activates the UPR system. Our results indicate that
this induction requires the full UPR signaling pathway con-
sistent with actual ER stress being responsible rather than
downstream perturbations of, for example, Hac1
i activity.
Third, we found that msc2 mutants show synthetic growth
defects when combined with mutations in either ire1 or
hac1. This observation is especially intriguing in light of
studies by Ng et al. (2000) in which mutations were identi-
fied that were synthetically lethal when combined with an
ire1 mutation. This screen identified 16 different genes al-
most all of which were shown to be involved in ER func-
tions such as glycosylation, GPI anchor synthesis, or ERAD
function. Thus, mutations in genes affecting lumenal ER
processing events are lethal when combined with ire1 muta-
tions. Although msc2 mutants were not identified in this
synthetic lethal screen, they too are synthetically lethal with
an ire1 mutation when cells are grown at 37 C. Finally, we
directly observed zinc-suppressible defects in one aspect of
ER function, ERAD. We chose to examine this process be-
cause Scj1, a chaperone protein of the ER lumen that is re-
quired for ERAD, is likely to be zinc dependent. One caveat
to this experiment is that the E3 ubiquitin-protein ligases re-
quired for proteasome degradation of unfolded proteins af-
ter their export from the ER, Hrd1/Der3, and Doa10/Ssm4,
may also be zinc dependent (Bordallo and Wolf 1999;
Swanson et al., 2001). Therefore, the defects in ERAD ob-
served in msc2 mutants could be due to disruption of ligase
function via alterations in cytosolic zinc homeostasis. This
Figure 9. Zinc deficiency induces the mammalian ER 
stress response. HeLa cells were transiently transfected 
with pSV- -galactosidase and p5xATF6GL3 plasmids. 
Cells were then subjected to different treatments, protein 
was extracted, and  -galactosidase and luciferase assays 
performed. Luminometer readings were normalized to 
 -galactosidase activity values to adjust for differences in 
transfection efficiencies. In all experiments, “un” refers to 
untransfected cells. (A) Luciferase activity in cells treated 
with ( Tm) and without ( Tm) tunicamycin (12 h, 2  M 
tunicamycin). (B) Time course of luciferase activity for 
cells treated with 5  M TPEN for 0, 1, 2.5, 5, or 12 h. 
(C) Concentration response of luciferase activity for cells 
treated with 0, 1, 2, 3, 4, or 5  M TPEN for 12 h. (D) Lu-
ciferase activity in cells with different 12-h treatments: no 
treatment (0), 5  M TPEN (TPEN), 5  M TPEN and 5
 M Zn (TPEN Zn), or 5  M Zn (Zn). The error bars
indicate   1 SD.332 The Journal of Cell Biology | Volume 166, Number 3, 2004
appears not to be the case; degradation of a model cytosolic
substrate of Doa10, the Deg1- -galactosidase protein (Swan-
son et al., 2001), was unaffected by either zinc limitation or
mutation of msc2 (unpublished data). Compromised func-
tion of Hrd1/Der3 is still formally possible but less likely
given the lack of effects on Doa10 function.
In addition to ERAD, it is also likely that other processes
occurring in the ER are impaired by zinc deficiency. Several
observations suggest that synthesis of GPI anchors may be
disrupted by these perturbations. First, GPI anchor synthesis
has been found to be zinc dependent both in vitro and in
vivo (Mann and Sevlever, 2001; Sevlever et al., 2001). Sec-
ond, the yeast MCD4, LAS21, and GPI13 genes encode re-
lated proteins required for GPI anchor synthesis (Gaynor et
al., 1999; Tohe and Oguchi, 1999; Flury et al., 2000; Taron
et al., 2000). These proteins all contain conserved domains
similar to the zinc-binding sites of alkaline phosphatases
(Galperin and Jedrzejas, 2001). Although the precise role of
these proteins is still unclear, their importance in GPI an-
chor synthesis is well documented. MCD4 and GPI13 are
essential genes whereas LAS21 is not. Temperature-sensitive
mcd4 alleles and las21 mutants have a large cell morphology
similar to that seen with msc2 (Mondesert et al., 1997; Li
and Kaplan, 2000; Ni and Snyder, 2001). Suppressors of
these mutations also link their activity to Msc2. The large
cell phenotype of las21 is suppressed by overexpression of
the HSP150 gene (Tohe and Oguchi, 1999). Hsp150 is a
cell wall protein of unknown function. We have found
HSP150 overexpression also suppresses the msc2 tempera-
ture-sensitive growth defect and large cell phenotype (un-
published data). Finally, MCD4 is a direct Zap1 target gene
and is induced greater than or equal to fourfold by zinc defi-
ciency (Lyons et al., 2000). These results suggest that GPI
anchor synthesis is sensitive to zinc deficiency, and MCD4 is
up-regulated to maintain sufficient activity in zinc-limited
cells. Golgi function was unimpaired by mutation of the
MSC2 gene; analysis of the kinetics of wild-type CPY pro-
cessing indicated no differences between wild-type and mu-
tant cells in high or low zinc (unpublished data).
In this work, we have identified three different transport-
ers that likely contribute to ER zinc: Zrc1, Cot1, and Msc2.
Of these three, Msc2 appears to play the predominant role
because mutation of this gene alone had the strongest effect
on UPR induction. Although Msc2 is resident in the ER
membrane, Zrc1 and Cot1 are most abundant in the vacu-
olar membrane (Li and Kaplan, 1998; MacDiarmid et al.,
2002). We can suggest two possible mechanisms to explain
how Zrc1 and Cot1 could supply zinc to the ER. First, these
proteins may mediate zinc transport soon after insertion into
the ER membrane and before their transit to the vacuole. Al-
ternatively, zinc may be transferred from the vacuole lumen
to the ER by retrograde vesicular trafficking.
The ZRC1 gene is a Zap1 target and induced by zinc defi-
ciency (Lyons et al., 2000; Miyabe et al., 2000). This was a
surprising finding given the importance of this transporter
in zinc storage and detoxification. Our previous results indi-
cated that ZRC1 up-regulation in low zinc is required to tol-
erate “zinc shock” (MacDiarmid et al., 2003). Zinc shock
occurs when zinc-limited cells, which express high levels of
the Zrt1 zinc uptake transporter, are resupplied with zinc.
The role of Zrc1 in supplying zinc to the ER is an additional
reason why the ZRC1 gene may be induced in low zinc; i.e.,
to maintain ER zinc levels. However, given the relatively mi-
nor role Zrc1 plays in maintaining ER function (Fig. 8), our
results argue that zinc shock tolerance is the major reason for
the regulation of ZRC1 expression by Zap1.
We also predict that additional pathways contribute to ER
zinc. UPR induction in the msc2 zrc1 cot1 triple mutant is
still suppressible by adding 10  M ZnCl2 to the medium.
One possible route to bypass the loss of Msc2, Zrc1, and
Cot1 activity is via fluid-phase endocytosis of zinc followed
by its retrograde vesicular transport to the ER. Although for-
mally possible, we do not favor this model based on our re-
sults. Specifically, although UPR induction in the msc2 zrc1
cot1 mutant is suppressed by 10  M zinc, it requires 100-
fold more zinc to suppress UPRE-lacZ activity in a zrt1 mu-
tant (Fig. 1 A). Zrt1 transports zinc across the plasma mem-
brane into the cytoplasm. Therefore, the much higher levels
of zinc required to suppress UPRE-lacZ expression in a zrt1
mutant strongly argues that zinc must pass through the cyto-
sol before entering the ER.
Msc2 is related to the Zhf protein of S. pombe (Borrelly et
al., 2002; Clemens et al., 2002). Like Msc2, Zhf is a mem-
ber of the CDF family of metal ion transporters. Further-
more, immunoelectron microscopy localized Zhf protein to
the ER membrane. However, the phenotypic effects of zhf
mutations argue that this protein plays a very different role
in zinc metabolism. Although Msc2 is important for supply-
ing zinc to the ER for organelle function, Zhf appears to be
required for zinc storage and detoxification. For example,
zhf mutations increase the sensitivity of cells to exogenous
zinc indicating its role in detoxification. zhf mutants also
have decreased zinc accumulation in cells indicating its role
in zinc storage. For Msc2, we found no effect of msc2 muta-
tions on zinc tolerance either in wild-type or zrc1 cot1 mu-
tant cells that are greatly sensitized to exogenous zinc (un-
published data). Li and Kaplan (2000) showed that msc2
mutants actually hyperaccumulate zinc. Thus, the effects of
zhf mutations in S. pombe are much more similar to muta-
tions altering Zrc1 and Cot1 of S. cerevisiae. The ER of S.
pombe may play a role in zinc storage and detoxification sim-
ilar to that of the vacuole in S. cerevisiae.
Another protein related to Msc2 is mammalian ZnT-5.
Although most members of the CDF family have only six
transmembrane domains, Msc2 and ZnT-5 are predicted to
have  15 transmembrane domains. For each, the conserved
CDF region is found at the COOH terminus with several
transmembrane domains attached to their NH2 termini.
ZnT-5 was localized to the Golgi when expressed from the
CMV promoter in HeLa cells and is widely expressed in
mammalian tissues (Kambe et al., 2002). Expression was es-
pecially high in the   cells of the pancreas in which zinc is
transported into secretory vesicles for the packaging of insu-
lin. Finally, ZnT-5–dependent zinc transport activity could
be observed in Golgi-derived vesicles in vitro. Given our re-
sults indicating that zinc transport into the secretory path-
way is important for ER stress and UPR induction, we pre-
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role in mammalian cells. Consistent with this hypothesis, we
have found that expression of ZnT-5 in msc2 mutant yeast
can suppress phenotypic defects of this mutant under certain
conditions (unpublished data).
Materials and methods
Yeast strains and growth conditions
Media used were YPD, SD, YPGE, and LZM as described previously (Gitan
et al., 1998). Strains used are described in Table I. Yeast deletion mutants
were obtained from Research Genetics. To generate several strains, the
KanMX cassette with 500 bp flanking the gene to be mutated was ampli-
fied by PCR from the appropriate mutant. The PCR fragment was then
transformed into the appropriate recipient strain. This method was used
to generate strains CEY3-8, CEY27-29, CM158, CM160, CM162, and
CM164. CM158 and CM164 were crossed to generate CEY25 and CM160
and CM162 were crossed to generate CEY26. CEY13 and CEY17 are hap-
loid segregants of CEY25 and 26, respectively. CEY8 and DY150 were
crossed to generate CEY24. CEY19-23 and CEY27-29 are haploid seg-
regants of CEY24.
Yeast plasmids
pDg2L (ZRE-lacZ; MacDiarmid et al., 2000), pHYC3 (HIS4-lacZ; Hinne-
busch et al., 1985), pMCZ-Y (UPRE-lacZ; provided by A. Cooper, Univer-
sity of Missouri-Kansas City; Kansas City, MO; Kawahara et al., 1997) were
described previously. pSN222 (Kex2-HA) was a gift of S. Nothwehr (Uni-
versity of Missouri). pRK315 (Pma1-HA) was a gift of R. Kölling (Heinrich-
Heine-Universität, Düsseldorf, Germany). pDN436 (CPY*–HA) was a gift
of D. Ng (Pennsylvania State University, University Park, PA). pGEV-TRP
was cotransformed with pRK315 so that Pma1-HA expression levels could
be controlled by  -estradiol (10
 7M; Sigma-Aldrich) addition (Gao and
Pinkham, 2000). pMCZ-YL was constructed by exchanging the URA3 gene
on pMCZ-Y with the LEU2 gene by marker swapping (Cross, 1997).
pDN436U was constructed by exchanging the LEU2 gene on pDN436
with the URA3 gene (Cross, 1997). To generate pMSC2, the MSC2 ORF
plus  500 bp of flanking DNA was amplified by PCR from genomic DNA
and inserted into EcoRI-, PstI-digested pFL38 by homologous recombina-
tion (Ma et al., 1987). Msc2 function was confirmed by complementing
the msc2 mutant. To generate pMSC2HA, the MSC2 ORF plus  500 bp
promoter and lacking the stop codon was PCR amplified from genomic
DNA and inserted into YCpZRC1-HA (MacDiarmid et al., 2002) by homol-
ogous recombination. The resulting plasmid has the MSC2 promoter and
ORF followed by three HA tags. The plasmid was confirmed by comple-
menting the msc2 mutant. To generate pHAC1, the HAC1 ORF plus
 1,300 bp upstream and  900 bp downstream flanking DNA were ampli-
fied from genomic DNA and inserted into SacI-, XmaI-digested pRS315 via
homologous recombination. To generate pHAC1
i, overlap PCR was used
to generate the HAC1 ORF (plus flanking DNA as above) without the in-
tron (Ho et al., 1989). This fragment was then inserted into pRS315 via ho-
mologous recombination. DNA sequencing confirmed the lack of the
intron.
Yeast  -galactosidase assays
 -Galactosidase assays were performed on protein extracts (Ausubel et al.,
1995) and specific activity was normalized to protein content.
Subcellular fractionation and immunoblotting
Subcellular fractionation was done largely as described by Roberg et al.
(1997). Lysates were fractionated on 20–60% sucrose gradients prepared
with 10 mM EDTA ( Mg) or with 2 mM MgSO4 ( Mg). Immunoblots were
done by standard techniques (Harlow and Lane, 1988). Blots were visual-
ized with ECL (Amersham Biosciences), and band quantitation was per-
formed using NIH Image 1.61. Antibodies used were mouse anti-HA
(12CA5, Roche), rabbit anti-HA (Sigma-Aldrich), mouse anti-Dpm1 (Mo-
Table I. Strains used in this work
Strain Genotype Reference
DY150 MATa ade2 can1 his3 leu2 trp1 ura3 Li and Kaplan, 2000
DY150 msc2 DY150 msc2::HIS3 Li and Kaplan, 2000
DY1457 MAT  ade6 can1 his3 leu2 trp1 ura3 Zhao and Eide, 1996a
ZHY1 DY1457  zrt1::LEU2 Zhao and Eide, 1996a
CM100 MAT  can1 his3 leu2 trp1 ura3 MacDiarmid et al., 2000
CM102 CM100 zrc1::HIS3 MacDiarmid et al., 2000
CM103 CM100 cot1::URA3 MacDiarmid et al., 2000
CM104 CM100 zrc1::HIS3 cot1::URA3 MacDiarmid et al., 2000
CM158 CM100 scj1::KanMX This work
CM160 CM100 jem1::KanMX This work
CM162 DY150 msc2::HIS3 scj1::KanMX This work
CM164 DY150 msc2::HIS3 jem1::KanMX This work
CEY3 DY150 ire1::KanMX This work
CEY4 DY150 hac1::KanMX This work
CEY5 DY150 msc2::HIS3 ire1::KanMX This work
CEY6 DY150 msc2::HIS3 hac1::KanMX This work
CEY7 CM100 msc2::KanMX  This work
CEY8, 27–29 CM100 msc2::KanMX zrc1::HIS3 cot1::URA3 This work
CEY13 DY150 jem1::KanMX  This work
CEY17 DY150 jem1::KanMX scj1::KanMX This work
CEY19–21 CM100 msc2::KanMX zrc1::HIS3 This work
CEY22, 23 CM100 msc2::KanMX cot1::URA3 This work
CEY24 DY150   CEY8 diploid
MATa/  can1/can1 ade2/ADE2 his3/his3 leu2/leu2 trp1/trp1 ura3/ura3 msc2::KanMX zrc1::HIS3 cot1::
URA3
This work
CEY25 CM158   CM164 diploid
MATa/  can1/can1 ade2/ADE2 his3/his3 leu2/leu2 trp1/trp1 ura3/ura3 msc2::HIS3 jem1::KanMX scj1::
KanMX
This work
CEY26 CM160   CM162 diploid
MATa/  can1/can1 ade2/ADE2 his3/his3 leu2/leu2 trp1/trp1 ura3/ura3 msc2::HIS3 jem1::KanMX scj1::
KanMX
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lecular Probes), mouse anti-Pgk1 (Molecular Probes), goat anti–mouse
HRP-conjugated secondary (Pierce Chemical Co.), and goat anti–rabbit
HRP-conjugated secondary (Pierce Chemical Co.).
Assay of ERAD
Yeast were grown in 200-ml cultures to an OD600    0.5. Cells were har-
vested and resuspended in 100 ml of fresh media to a final OD600    1.0.
Cells were grown 30 min, then cycloheximide (Sigma-Aldrich) was added
to a final concentration of 100  g/ml. 5 ml aliquots of cells were removed
at each time point to tubes containing NaN3 to a final concentration of 10
mM. After the last time point, the cells were collected by centrifugation
and washed once with cold buffer containing 10 mM NaN3, 1 mM EDTA.
Cells were resuspended in 1 ml of the same buffer and transferred to mi-
crofuge tubes. Cells were pelleted and resuspended in 200  l cold protein
extraction buffer (10 mM Tris-Cl, pH 8, 25 mM ammonium acetate, 1 mM
EDTA, 1 mM PMSF, 10% trichloroacetic acid [Sigma-Aldrich], yeast pro-
teinase inhibitor cocktail [complete mini EDTA-free pellets; Roche]). An
equal volume of glass beads was added and the tubes were vortexed five
times for 1 min, with 1 min on ice between pulses. Lysates were trans-
ferred to fresh tubes. Another 500  l of protein extraction buffer was
added to the glass beads, vortexed 1 min, and then pooled with the previ-
ous lysates. Lysates were centrifuged at 14,000 g at 4 C for 10 min. The su-
pernatant was removed and discarded. The pellets were resuspended in
120  l buffer I (100 mM Tris base, 3% SDS, 1 mM PMSF), then boiled for 5
min. Insoluble debris was pelleted by centrifuging 5 min at 15,800 g. The
supernatant was transferred to new tubes and protein concentrations were
measured using the DC protein kit (Bio-Rad Laboratories). 10  g of protein
were loaded per lane when analyzed by immunoblotting.
Cell culture, transient transfection, mammalian plasmids, and assays
HeLa cells were cultured in DME (Invitrogen) plus 0.45% glucose under
5% CO2. All media contained 100 U/ml penicillin, 100  g/ml streptomy-
cin, 2 mM L-glutamine, and 100  M MEM nonessential amino acids (Invi-
trogen) supplemented with 10% FBS (Invitrogen). p5xATF6GL3 was a gift
of R. Prywes (Columbia University, New York, NY), and contains five re-
peats of an ATF6 binding site cloned into a minimal promoter preceding
the firefly luciferase gene (Wang et al., 2000). pSV- -galactosidase control
vector (Promega) was used as a control for transfection efficiency. HeLa
cells ( 1.2   10
6) were seeded in 60-mm plates and transiently trans-
fected using Lipofectamine 2000 (Invitrogen). Both p5xATF6GL3 and
pSV- -galactosidase plasmids were cotransfected in all experiments. Trans-
fection efficiencies were typically 60%. 36–48 h after transfection, tuni-
camycin (Sigma-Aldrich), ZnCl2, or TPEN (Sigma-Aldrich) was added to the
culture media at the indicated concentrations. After treatment, the cells
were washed three times with cold PBS. To generate protein extracts and
perform luciferase and  -galactosidase assays, the luciferase assay system
with reporter lysis buffer (Promega) was used. Luciferase activity was nor-
malized to  -galactosidase activity as an internal control.
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